Efficacy of CED for malignant glioma to date has been mixed, but improvements in technology and therapeutic agents arepromising.
No takes yet. Share an insight, caveat, or question.
Kreatsoulas et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: